Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 14.07.2023
Coreo AG
- FY 2022 was marked by portfolio optimisation
- Postponed investments should be realised in 2024
- Break-even expected from 2024
In the past financial year 2022, Coreo AG's focus was on active asset
management of the existing portfolio, whereas no new investments were made
for the first time since the start of real estate-related business [ … ]
Fri, 14.07.2023
HAEMATO AG
- Compulsory manufacturer discounts burden 'Specialty Pharma' segment
- Lifestyle & Aesthetics' segment should grow in 2023; high potentials
available with Botox launch
- Increase in profitability expected
As expected, HAEMATO AG reports a decline in revenue to € 248.14 million
(previous year: € 285.04 million) for the past f [ … ]
Fri, 14.07.2023
HAEMATO AG
- Compulsory manufacturer discounts burden 'Specialty Pharma' segment
- Lifestyle & Aesthetics' segment should grow in 2023; high potentials
available with Botox launch
- Increase in profitability expected
As expected, HAEMATO AG reports a decline in revenue to € 248.14 million
(previous year: € 285.04 million) for the past f [ … ]
Wed, 12.07.2023
Advanced Blockchain AG
Considerable upside potential to portfolio valuation. Track record of
successful partial divestments and financing rounds.
In 2022, Advanced Blockchain AG expanded its portfolio by investing in 12
promising blockchain projects and Web3 infrastructure initiatives. Also
three in-house portfolio companies secured over $53 million in funding f [ … ]
Wed, 12.07.2023
Advanced Blockchain AG
Considerable upside potential to portfolio valuation. Track record of
successful partial divestments and financing rounds.
In 2022, Advanced Blockchain AG expanded its portfolio by investing in 12
promising blockchain projects and Web3 infrastructure initiatives. Also
three in-house portfolio companies secured over $53 million in funding f [ … ]
Tue, 11.07.2023
Cenit AG
Inorganic growth continues with the second acquisition in 2023; price
target and rating unchanged
With the announcement of 06.07.2023, CENIT AG is continuing its inorganic
growth course with the acquisition of Berlin-based PI Informatik GmbH. The
company, which has been in existence since 1996, is a full service provider
in the field of co [ … ]
Tue, 11.07.2023
Cenit AG
Inorganic growth continues with the second acquisition in 2023; price
target and rating unchanged
With the announcement of 06.07.2023, CENIT AG is continuing its inorganic
growth course with the acquisition of Berlin-based PI Informatik GmbH. The
company, which has been in existence since 1996, is a full service provider
in the field of co [ … ]
Thu, 22.06.2023
Aspermont Ltd
Growth even facing headwinds market conditions. Renowned top executive and
management hiring. Forecast focus on return to double digit growth.
Facing headwinds but growing. The revenues are up 1% YoY, reaching $9.36m
AUD. Revenues are in line with company’s guidance.
Increased net liquidity asset. The company has a net liquidi [ … ]
Thu, 22.06.2023
Aspermont Ltd
Growth even facing headwinds market conditions. Renowned top executive and
management hiring. Forecast focus on return to double digit growth.
Facing headwinds but growing. The revenues are up 1% YoY, reaching $9.36m
AUD. Revenues are in line with company’s guidance.
Increased net liquidity asset. The company has a net liquidi [ … ]
Tue, 20.06.2023
Media and Games Invest SE
Financial year 2022 closed with a significant improvement in revenue and
operating profit; A continuation of the profitable growth course is
expected for 2023; The expansion of the ad tech platform business should
lead to significant revenue and earnings growth in the future; Target
price: € 5.30 (previously: € 5.40); Rating: BUY
[ … ]